Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for pharma
Pharma & Biotech Patent Litigation in Europe conference returns with IPKat readers’ discount Pharma & Biotech Patent Litigation in Europe conference returns with IPKat readers’ discount Reviewed by Dr Rose Hughes on Friday, April 24, 2026 Rating: 5
Annual Conference on EU Law in the Pharmaceutical Sector returns with IPKat readers’ discount Annual Conference on EU Law in the Pharmaceutical Sector returns with IPKat readers’ discount Reviewed by Eleonora Rosati on Thursday, February 12, 2026 Rating: 5
Fordham 32 (Report 1): Patents in Pharma Fordham 32 (Report 1): Patents in Pharma Reviewed by Annsley Merelle Ward on Thursday, April 24, 2025 Rating: 5
'Annual Conference on EU Law in the Pharmaceutical Sector 2025' returns to Brussels and online with 25% IPKat readers’ discount 'Annual Conference on EU Law in the Pharmaceutical Sector 2025' returns to Brussels and online with 25% IPKat readers’ discount Reviewed by Eleonora Rosati on Thursday, February 06, 2025 Rating: 5
Pharma & Biotech Patent Litigation Summit (& UPC Litigation Forum) returns to Amsterdam in January with 15% IPKat readers’ discount Pharma & Biotech Patent Litigation Summit (& UPC Litigation Forum) returns to Amsterdam in January with 15% IPKat readers’ discount Reviewed by Eleonora Rosati on Tuesday, November 26, 2024 Rating: 5
Pharma & Biotech Patent Litigation Summit (& UPC Litigation Forum) returns to Amsterdam with 15% IPKat readers’ discount Pharma & Biotech Patent Litigation Summit (& UPC Litigation Forum) returns to Amsterdam with 15% IPKat readers’ discount Reviewed by Eleonora Rosati on Wednesday, September 25, 2024 Rating: 5
Pharma and Biotech Patent Litigation Summit returns to Amsterdam with IPKat readers’ discount Pharma and Biotech Patent Litigation Summit returns to Amsterdam with IPKat readers’ discount Reviewed by Eleonora Rosati on Tuesday, October 10, 2023 Rating: 5
The current uncertainty over duration of patent rights in Ukraine The current uncertainty over duration of patent rights in Ukraine Reviewed by Anastasiia Kyrylenko on Wednesday, November 16, 2022 Rating: 5
InformaConnect pharma events return with IPKat readers’ discount InformaConnect pharma events return with IPKat readers’ discount Reviewed by Eleonora Rosati on Monday, July 25, 2022 Rating: 5
‘Competition law in the pharmaceutical sector’ conference returns with IPKat readers’ discounted fee ‘Competition law in the pharmaceutical sector’ conference returns with IPKat readers’ discounted fee Reviewed by Eleonora Rosati on Tuesday, October 26, 2021 Rating: 5
‘Competition Law in the Pharmaceutical Sector’ returns to Brussels with IPKat discount code ‘Competition Law in the Pharmaceutical Sector’ returns to Brussels with IPKat discount code Reviewed by Eleonora Rosati on Wednesday, October 30, 2019 Rating: 5
IP Pharma Challenges ... in Stockholm IP Pharma Challenges ... in Stockholm Reviewed by Eleonora Rosati on Thursday, May 30, 2019 Rating: 5
Fordham 27 (Report 12): SPCs Fordham 27 (Report 12): SPCs Reviewed by Annsley Merelle Ward on Tuesday, April 30, 2019 Rating: 5
Discount codes available for IPKat readers interested in copyright or in pharma law Discount codes available for IPKat readers interested in copyright or in pharma law Reviewed by Eleonora Rosati on Monday, October 29, 2018 Rating: 5
Fordham 25 (Report 7): Pharma, IP & Competition Fordham 25 (Report 7): Pharma, IP & Competition Reviewed by Annsley Merelle Ward on Tuesday, April 25, 2017 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.